No Detail Found!

Preliminar y Assessment of Newly Developed Escherichia coli Mastitis Vaccines in Laborator y Animals: Promising Results

Author(s)
Saira Jabeen Department of Veterinary Medicine, University of Veterinary and Animal Sciences,Lahore-54000-,Pakistan
Muhammad Avais Department of Veterinary Medicine, University of Veterinary and Animal Sciences,Lahore-54000-,Pakistan
Jawaria Ali Khan Department of Veterinary Medicine, University of Veterinary and Animal Sciences,Lahore-54000-,Pakistan
Kamran Ashraf Department of Parasitology, University of Veterinary and Animal Sciences,Lahore-54000-,Pakistan
Aftab Ahmad Anjum Institute of Microbiology, University of Veterinary and Animal Sciences,Lahore-54000-,Pakistan
Abstract
Escherichia coli is recognized as an environmental mastitis pathogen and a significant contributor to clinical mastitis cases in dairy cows. Due to environmental nature of this pathogen, conventional mastitis control measures often prove ineffective. Hence, the endeavor to combat E. coli mastitis through vaccination appears feasible and economically prudent. This study was aimed at preparation and evaluation of mastitis vaccines prepared by using local E. coli isolate, bearing the aggR gene, derived from mastitis cases in dairy cows. Prior to embarking on vaccine preparation, the immunogenicity of this E. coli (aggR) strain was determined across various concentrations in a cohort of 20 locally bred rabbits. For preparation of vaccines, the antigen concentration was adjusted to 10^10 cells/mL, a level determined to trigger highest IHA antibody response in rabbits. Three distinct vaccine types were prepared, each employing different adjuvants. To ensure the quality and safety of these vaccines, quality control assessment was carried out. The efficacy evaluation of the vaccines was performed on 24 locally bred rabbits, divided into 4 groups. Each group received a different type of vaccine, with booster doses at 15-day intervals following the priming. Serum samples were collected biweekly over a 60-day period, and the antibody titers were measured using IHA test. Geometric mean titers (GMT) were computed and subsequently analyzed statistically. The results indicated that the E. coli (aggR) isolate exhibited immunogenicity in rabbits, with the antigen concentration of 10^10 cells/mL yielding highest antibody titers. Vaccines demonstrated sterility and safety, exhibiting no adverse effects when administered to laboratory animals. Furthermore, upon comparing the effectiveness of the vaccines, it became evident that the Montanide-adjuvanted vaccine elicited significantly higher antibody titers (P<0.05) in comparison to the plain vaccine or the aluminum hydroxideadjuvanted vaccine. Challenge protection assay revealed that Montanide and aluminum adjuvanted vaccines had 100% survival rate among rabbits compared to 16.7% of placebo group. It was concluded that newly developed E. coli (aggR) mastitis vaccines have promising results to combat E. coli mastitis in dairy cows.
Publication Details
Page(s) 53-60
Published Journal: Punjab University Journal of Zoology, Volume: 39, Issue: 1, Year: 2024

Request the full text from PASTIC

Keywords
Rabbits, Mastitis, Evaluation, coli, vaccine, Mastitis, E, IHA
References
Ahmad T.,Muhammad G. .2008 .Evaluation of Staphylococcus aureus and Streptococcus agalactiae aluminium hydroxide adjuvanted mastitis vaccine in rabbits. Pakistan J. Agric. Sci., 45 : 353-361.
Athar M. .2007 .Preparation and evaluation of inactivated polyvalent vaccines for the control of mastitis in dairy bufaloes. PhD dessertation, : .
Brugh M.,Jr M. .1978 .A simple method for recording and analyzing serological data. , 22 : 362-365.
Butt A.A. .2006 .Evaluation of four adjunvanted trivalent vaccines for the control of mastits in dairy bufaloes and cows. PhD dissertation, : .
Cobirka M.,Tancin V.,Slama P. .2020 .Epidemiology and classification of mastitis. Animals (Basel), 10 : 2212.
Cook D.R.,Hill H.T.,Kinker D.R. .1990 .Eficacy of a killed gpX deleted pseudorabies virus vaccine. Can. J. Vet. Res., 54 : 438.
Gao J.,Barkema H.W.,Liu L.,Deng G.,Cai Z.,Shan L.,R. L.,Zou S.,Kastelic J.,J.P. J. .2017 .Incidence of clinical mastitis and distribution of pathogens on large Chinese dairy farms. J. Dairy Sci., 100 : 12334-4806.
Giraudo J.A.,Calzolari A.,Rampone H.,Rampone A.,Giraudo A.T.,Bogni C.,Larriestra A.,Nagel R. .1997 .Field trials of a vaccine against bovine mastitis. Evaluation in heifers. J. Dairy Sci., 0302(97) : 76006-5.
Hirsch J.G.,Strauss B. .1964 .Studies on heat-labile opsonin in rabbit serum. J. Immunol., 92 : 145-154.
Ismail Z.B. .2017 .Mastitis vaccines in dairy cows: Recent developments and recommendations of application. Vet, 1057 : 1062-1062.
Murrad S.,Ali M.A.,Rabbani M.,Anjum A.A.,Avais M.,Yaqub T.,Harrar Z.F. .2019 .Antibiotic resistance pattern of mastitis causing Escherichia coli toxinotypes. Pak, 40 : 264-266.
Nickerson S.C.,Ryman V. .2024 .2. downloaded on March 12, : .
Opdebeeck J.,Norcross N. .1985 .Immunogenic properties of Staphylococcus aureus and Streptococcus agalactiae administered separately and in combination to lactating cows. Aust, 62 : 0813-116.
Partington J.R. .1961 .Martin's Press.. , : .
Rahman S.,Athar M.,Shakoor A.,Muhammad G.,Butt A. .2005 .Standardization of indirect haemagglutination test for titration of antibody against Staphylococcus aureus, Streptococcus agalactiae and Escherichia coli isolated from bubaline mastitis. Int. J. Agric. Biol, 7 : 441-444.
Seegers H.,Fourichon C.,Beaudeau F. .2003 .Production efects related to mastitis and mastitis economics in dairy cattle herds. Vet. Res, 34 : 475-491.
Shakoor A. .2006 .Preparation and evaluation of Staphylococcus aureus vaccines for the control of mastitis in dairy bufaloes (Bubalus bubalis). PhD Dessertation, : .
Tomasinsig L.,De Conti G.,Skerlavaj B.,Piccinini R.,Mazzilli M.,D'Este F.,Tossi A.,Zanetti M. .2010 .Broad-spectrum activity against bacterial mastitis pathogens and activation of mammary epithelial cells support a protective role of neutrophil cathelicidins in bovine mastitis. Infect. Immun., 78 : 09-1788.
Tripathi N.,Sapra A.,Island (FL): StatPearls Publishing A. .2023 .. [Updated 2023 Aug, 2024 : Jan.
Watson D.,McColl M.,Davies M. .1996 .Field trial of a Staphylococcal mastitis vaccine in dairy herds: clinical, subclinical and microbiological assessments. Aust, 74 : 0813-450.
Yousaf M. .2009 .Evaluation of some non-antibiotic antibacterials in the treatment of bubaline mastitis. , : .
Zhao X.,Lacasse P. .2008 .Mammary tissue damage during bovine mastitis: Causes and control. J. Anim. Sci., 86 : 0302-65.
Zigo F.,Farkašová Z.,Výrostková J.,Regecová I.,Ondrašovičová S.,Vargová M.,Sasáková N.,Pecka-Kielb E.,Bursová E.,Kiss D.S. .2022 .Dairy cows udder pathogens and occurrence of virulence factors in Staphylococci. Animals (Basel), 12 : 470.
Zigo F.,Vasil M.,Ondrašovičová S.,Výrostková J.,Bujok J.,Pecka-Kielb E. .2021 .Maintaining optimal mammary gland health and prevention of mastitis. , 8 : 607311.
0

Citations

0

Downloads

58

Views